carbamazepine , the primary agent for trigeminal neuralgia , suppressed such a paroxysmal response , suggesting that an analgesic action of the drug results from the suppression of synaptic transmission at the subnucleus reticularis dorsalis and trigeminal subnucleus caudalis .
C0006949
carbamazepine
C0040997
trigeminal neuralgia